

Representative Lee Jung-seok (6th from left) and the winnersDaewon Pharmaceutical's "Coldewon" and Sanofi's "Honey Jam Market for Those Who Can't Sleep" won the grand prize in the advertising and PR categories at the 2022 Korea Pharmaceutical Bio-Industry Advertising and PR Awards.
Chong Kun Dang Benfobell won the grand prize in the "Special Award for Pharmacist Selection" category, which was decided by the votes of pharmacists.
Dailypharm (CEO Lee Jung-seok) held an award ceremony for the 2022 Korea Pharmaceutical Bio-Industry Advertising and PR Awards at the Diamond Hall of InterContinental Seoul COEX Hotel on the 7th.
More than 200 advertising and public relations officials from domestic and foreign pharmaceutical bio companies, including Won Hee-mok and Lee Young-shin, vice chairman of KRPIA, attended the event.
At the ceremony, which marks its 10th anniversary this year, a total of 72 works were submitted in five categories, including TV, printing and radio, the Internet, and PR.
The advertising sector was divided into two categories: TV, Internet, and radio.
The grand prize in each field and three excellence awards were selected along with the grand prize.
In the PR category, the grand prize, one grand prize, and three excellence awards were honored.
A special award was also given to 1,300 pharmacists who voted directly.
Daewon Pharmaceutical's Coldewon won the grand prize in this year's advertising category.
The award-winning work was awarded a prize of 5 million won along with the trophy.
Yoo Seong-kwon, director of Daewon Pharmaceutical, said, "This year seems to have been a year when Coldewon received a lot of attention and took a leap forward.
I am grateful that I received that energy and received a good award, he said.
"I will try to stand here next year with good advertisements for new items." In the TV category, Shinshin Pharmaceutical's Arex was selected as the best prize, and a prize of 3 million won was given along with the trophy.
▲ Sanofi Allegra, ▲ Ildong Pharmaceutical's Aronamin C Plus Tab, and ▲ Limited's Mag-B Speed Excellence Award.
The excellence award was awarded a trophy and a prize of 2 million won.
In the Internet/radio category, HKinno.N's "Condition" won the grand prize.
▲Houns Radio Corporate Advertising ▲ Johnson & Johnson Nicorette ▲ JW Pharmaceutical 'Himom bands' were selected for the Excellence Awards.
The award-winning film was given a trophy and prize money.
In the PR sector, there were many entries that threw meaningful messages, including social contribution activities.
This year's PR category was won by Sanofi's campaign to improve awareness of atopic dermatitis diseases, Honey Jam Market for those who can't sleep.
The award-winning work was awarded a prize of 5 million won along with the trophy.
Kim Hyun-jung, director of Sanofi Specialty Care, said, "We have been campaigning to improve awareness of atopic dermatitis diseases for four years since 2019.
This year, the "Honey Jam Market for People Who Can't Sleep" was held to form a consensus on the physical and mental pain of patients.
It is an honor that the patient's sincerity has paid off with a good award.
"I will continue to make efforts to hold various campaigns for patients," he said.
▲Ginexin, the god of memory (SK Chemical) ▲Growup Bio-Up Campaign (Amgen Korea) ▲YYPharm, including blood donation of love, won the Excellence Award.
In the special prize category selected by online voting of 1,300 pharmacists, Chong Kun Dang was selected as the Benfobell target and won a trophy and 5 million won in prize money.
Lee Sang-soo, deputy director of Chong Kun Dang, said, "Since the launch of Benfobell, it has been loved by pharmacists so far.
It has a special meaning because pharmacists voted for it themselves.
I think it's thanks to your consistent communication with us.
"I'll be Benfobell who works harder." Donghwa Pharmaceutical Itchi won the grand prize in the special award for pharmacist selection.
▲Master Pharmaceutical Mayqueen ▲ Dong-A Pharmaceutical Panpyrin and others received the Excellence Award.
Ahn Dae-cheon, former chairman of the Korea Advertising Association (Professor of Inha University), was the judge, while Chung Jae-hoon, a professor at Chonbuk National University, and Lee Jae-guk, executive director of the Korea Pharmaceutical Bio Association, participated as professional judges.
Ahn, chairman of the judging committee, said, "The review of the advertising sector was based on whether the message was well matched and clearly delivered, secondly on the novelty of the idea, and thirdly on the reliability of the information.
The PR division considered whether it could contribute to enhancing its image from a long-term perspective and whether messages and activities could elicit timely and consumer sympathy, he said.
"We praise your efforts to develop advertising and promotion in the pharmaceutical bio industry." The Korea Pharmaceutical Bio-Industry Advertising and PR Awards began in 2013 with the aim of encouraging advertising promoters who give new values to the pharmaceutical industry and drugs and encouraging pharmacists, who are primarily advertising consumers, to produce advertisements that form a consensus.
Lee Jung-seok, CEO of dailypharm, said in a greeting, "Many excellent works have been submitted this year, so I would like to thank pharmaceutical bio officials.
I would like to congratulate you on your award-winning work.
"We will make it a more fruitful and beneficial event next year," he said.
At the same time, as the subject of the information is digitally transferred to consumers, changes are taking place in general drug advertisements, he said.
"I hope it will be a place to find a new paradigm of general drug advertisements." "Thank you to Daily Farm for planning the advertising and PR targets," he said.
Vice Chairman Lee Young-shin said, "With the development of artificial intelligence and digital healthcare, it has become an era of understanding the development of science and technology in the global beyond Korea.
Advertising and promotion of drugs is no exception, he said.
"I would like to thank advertising and public relations officials and media officials who have recognized new changes and delivered more accurate information in the regulated healthcare industry and contributed to improving the quality of life of the people." "KRPIA will also make efforts to grow with the domestic pharmaceutical bio industry."
댓글 운영방식은
댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.
댓글 노출방식은
댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.
댓글의 삭제 기준은
다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.
저작권·인격권 등 타인의 권리를 침해하는 경우
상용 프로그램의 등록과 게재, 배포를 안내하는 게시물
타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물
근거 없는 비방·명예를 훼손하는 게시물
특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우
특정 지역 및 종교간의 감정대립을 조장하는 내용
사실 확인이 안된 소문을 유포 시키는 경우
욕설과 비어, 속어를 담은 내용
정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)
특정 지역이나 단체를 비하하는 경우
특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우
특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우
타인의 ID 혹은 닉네임을 도용하는 경우
게시판 특성상 제한되는 내용
서비스 주제와 맞지 않는 내용의 글을 게재한 경우
동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우
부분적으로 변경하여 반복 게재하는 경우도 포함
제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우
돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물
게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우
수사기관 등의 공식적인 요청이 있는 경우
기타사항
각 서비스의 필요성에 따라 미리 공지한 경우
기타 법률에 저촉되는 정보 게재를 목적으로 할 경우
기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용
사실 관계 확인 후 삭제
저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우
타인의 초상권을 침해하거나 개인정보를 유출하는 경우
당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)
※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.
※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.
※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.